Viewing StudyNCT00390143



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00390143
Status: COMPLETED
Last Update Posted: 2016-10-25
First Post: 2006-10-17

Brief Title: Study in AdolescentsAdults to Evaluate the Persistence up to 35 Yrs of GSK Biologicals Meningococcal Vaccine 134612
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-02
Start Date Type: None
Primary Completion Date: 2009-05
Primary Completion Date Type: ACTUAL
Completion Date: 2009-05
Completion Date Type: ACTUAL
First Submit Date: 2006-10-17
First Submit QC Date: October 17 2006
Study First Post Date: 2006-10-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2009-09-03
Disp First Submit QC Date: September 3 2009
Disp First Post Date: 2009-09-04
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-10-21
Last Update Post Date: 2016-10-25
Last Update Post Date Type: ESTIMATED